Novartis commits $23 billion to expand U.S. manufacturing and R&D with 10 new facilities, aiming to produce all key U.S.

On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...

Swiss-pharmaceutical giant, Novartis, announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

The Swiss pharmaceutical company Novartis has announced significant investments in the US, days after President Donald Trump ...

Swiss pharmaceutical giant Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities, ...

By Patrick Wingrove (Reuters) -Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 ...

Swiss pharma group Novartis has said it will expand its US manufacturing and research and development with a $23bn investment over five years, as drugmakers reconfigure their supply chains as part of ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

NEW YORK] Swiss pharmaceutical giant Novartis said it would invest US$23 billion in the US over the next five years to ensure ...

It joins a growing number of multinational drug companies to announce investments in the US. Read more at straitstimes.com.

By Patrick Wingrove (Reuters) -Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 ...

Swiss pharmaceutical giant Novartis AG said it would invest $23 billion in the US over the next five years to ensure all its ...